Pre-treatment with P2Y12 inhibitors in ACS is unnecessary and risky – CON.
14 March 2021 (00:37 - 00:44)
Organised by:
Slides
About the speaker
Duke University Medical Center, Durham (United States of America)
5 More presentations in this session
Professor K. Huber (Vienna, AT)
Professor R. Welsh (Edmonton, CA)
Professor A. Kastrati (Munich, DE)
Access the full session
The Event
ACVC 2021
14 March 2021
00:37 CET
